Cargando…

Elucidating the antiviral potential of polysaccharides

Detalles Bibliográficos
Autores principales:	Fatima, Rabab, Sharma, Mousmee, Prasher, Parteek, Gupta, Gaurav, Singh, Kumar, Gulati, Monica, Dua, Kamal
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Leibniz Research Centre for Working Environment and Human Factors 2023
Materias:	Letter to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9939763/ https://www.ncbi.nlm.nih.gov/pubmed/36814852 http://dx.doi.org/10.17179/excli2022-5621

Ejemplares similares

Adenocarcinoma - success so far and the way ahead
por: Fatima, Rabab, et al.
Publicado: (2023)

Mucoadhesive nanoformulations and their potential for combating COVID-19
por: Prasher, Parteek, et al.
Publicado: (2021)

Luteolin: a flavonoid with a multifaceted anticancer potential
por: Prasher, Parteek, et al.
Publicado: (2022)

Nanotechnology-based self-sterilizing surfaces and their potential in combating coronavirus disease 2019
por: Prasher, Parteek, et al.
Publicado: (2021)

Vesicular drug-delivery systems as theranostics in COVID-19
por: Satija, Saurabh, et al.
Publicado: (2020)

Emerging prospects of vitamin D3 in metabolic syndrome: A proof of concept (POC) approach targeting inflammation
por: Singh, Yogendra, et al.
Publicado: (2020)

Targeting mucin hypersecretion in COVID-19 therapy
por: Prasher, Parteek, et al.
Publicado: (2022)

Recent developments in the role of protocatechuic acid in neurodegenerative disorders
por: Thapa, Riya, et al.
Publicado: (2023)

Spermidine as a promising anticancer agent: Recent advances and newer insights on its molecular mechanisms
por: Prasher, Parteek, et al.
Publicado: (2023)

Advanced drug delivery systems can assist in targeting coronavirus disease (COVID-19): A hypothesis
por: Mehta, Meenu, et al.
Publicado: (2020)

Activation of TWEAK/Fn14 signaling suppresses TRAFs/NF-?B pathway in the pathogenesis of cancer
por: Gupta, Gaurav, et al.
Publicado: (2021)

A novel nano therapeutic using convalescent plasma derived exosomal (CP(Exo)) for COVID-19: A combined hyperactive immune modulation and diagnostics
por: Anand, Krishnan, et al.
Publicado: (2021)

Plants derived therapeutic strategies targeting chronic respiratory diseases: Chemical and immunological perspective
por: Prasher, Parteek, et al.
Publicado: (2020)

Microfluidic chips: recent advances, critical strategies in design, applications and future perspectives
por: Pattanayak, Prapti, et al.
Publicado: (2021)

Advances in Lung Cancer Treatment Using Nanomedicines
por: Sharma, Akshansh, et al.
Publicado: (2022)

Rediscovering the Therapeutic Potential of Agarwood in the Management of Chronic Inflammatory Diseases
por: Alamil, Juman Mohammed Rasmi, et al.
Publicado: (2022)

Advances and applications of monoolein as a novel nanomaterial in mitigating chronic lung diseases
por: Chan, Yinghan, et al.
Publicado: (2022)

Recent updates on neuropharmacological effects of luteolin
por: Gupta, Gaurav, et al.
Publicado: (2018)

Recent update on biological activities and pharmacological actions of liraglutide
por: Tiwari, Juhi, et al.
Publicado: (2017)

Anticonvulsant effect of liraglutide, GLP-1 agonist by averting a change in GABA and brain glutathione level on picrotoxin-induced seizures
por: Gupta, Gaurav, et al.
Publicado: (2017)

Interferon therapy for preventing COPD exacerbations
por: Mehta, Meenu, et al.
Publicado: (2020)

Cytotoxic mechanisms of berberine-phytantriol liquid crystalline nanoparticles against non-small-cell lung cancer
por: Paudel, Keshav Raj, et al.
Publicado: (2023)

Recent update on barbiturate in relation to brain disorder
por: Pathak, Sachchidanand, et al.
Publicado: (2021)

Current update on the protective effect of epicatechin in neurodegenerative diseases
por: Thapa, Riya, et al.
Publicado: (2022)

Female gender as a risk factor for developing COPD
por: Shukla, Shakti D., et al.
Publicado: (2021)

Current update on the protective effect of naringin in inflammatory lung diseases
por: Gupta, Gaurav, et al.
Publicado: (2022)

Preventive role of Sapindus species in different neurological and metabolic disorders
por: Rawat, Sarita, et al.
Publicado: (2022)

Current biological and pharmacological updates on wogonin
por: Rawat, Sarita, et al.
Publicado: (2020)

COVID-19 in underlying COPD Patients
por: Sunkara, Krishna, et al.
Publicado: (2021)

Interplay of Gut Microbiota in Polycystic Ovarian Syndrome: Role of Gut Microbiota, Mechanistic Pathways and Potential Treatment Strategies
por: Corrie, Leander, et al.
Publicado: (2023)

The FBXW7‐NOTCH interactome: A ubiquitin proteasomal system‐induced crosstalk modulating oncogenic transformation in human tissues
por: Kar, Rohan, et al.
Publicado: (2021)

Aminoglycosides and their potential as SARS-CoV-2 antivirals
por: Cimolai, Nevio
Publicado: (2021)

Polysaccharides and Their Derivatives as Potential Antiviral Molecules
por: Claus-Desbonnet, Hadrien, et al.
Publicado: (2022)

Concepts of advanced therapeutic delivery systems for the management of remodeling and inflammation in airway diseases
por: Dhanjal, Daljeet Singh, et al.
Publicado: (2022)

Repurposing Hepatitis C Direct-Acting Antivirals Against COVID-19
por: Kumar, Pramod, et al.
Publicado: (2021)

Nanomedicine and medicinal plants: Emerging symbiosis in managing lung diseases and associated infections
por: Paudel, Keshav Raj, et al.
Publicado: (2022)

Microbial determinants of arthritis
por: Shukla, Shakti D., et al.
Publicado: (2020)

The inconvenient corollaries of a convenient antiviral regime
por: Mehta, Hitaishi, et al.
Publicado: (2022)

Antiviral and anti-inflammatory properties of ivermectin and its potential use in Covid-19()
por: Portmann-Baracco, Arianna, et al.
Publicado: (2020)

Victims of armed conflict in India: psychosocial impact and available support
por: Sharma, Vasudha, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_q3lsqvk1mdtprkisd6q2ji42cc